Detalhe da pesquisa
1.
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging.
Int J Mol Sci;
24(3)2023 Feb 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36769215
2.
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease.
Int J Cancer;
150(8): 1357-1372, 2022 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34927257
3.
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassification.
Br J Cancer;
127(7): 1270-1278, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35864156
4.
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict).
Breast Cancer Res Treat;
191(2): 327-333, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34783927
5.
Increasing the efficiency of hyperthermic intraperitoneal chemotherapy (HIPEC) by combination with a photosensitive drug in pediatric rhabdomyosarcoma in an animal model.
Pediatr Blood Cancer;
69(11): e29864, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35731577
6.
Establishment of a new valid animal model for the evaluation of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric rhabdomyosarcoma.
Pediatr Blood Cancer;
68(11): e29202, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34197033
7.
What turns CREB on? And off? And why does it matter?
Cell Mol Life Sci;
77(20): 4049-4067, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32347317
8.
Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles.
J Pathol;
248(4): 421-437, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30982971
9.
An analysis of PIK3CA hotspot mutations and response to neoadjuvant therapy in breast cancer patients from four prospective clinical trials.
Clin Cancer Res;
2024 Jun 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38837894
10.
Nodal lymphangiogenesis and immunophenotypic variations of sinus endothelium in sentinel and non-sentinel lymph nodes of invasive breast carcinoma.
PLoS One;
18(1): e0280936, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36693068
11.
High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin.
J Pathol Clin Res;
9(6): 498-509, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37608427
12.
[Clinically relevant molecular pathological diagnostics in breast cancer]. / Klinisch relevante molekularpathologische Diagnostik beim Mammakarzinom.
Pathologie (Heidelb);
44(1): 39-49, 2023 Feb.
Artigo
em Alemão
| MEDLINE
| ID: mdl-36629894
13.
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
J Ovarian Res;
16(1): 150, 2023 Jul 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37525239
14.
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer.
Neoplasia;
44: 100934, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37703626
15.
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma.
Hum Pathol;
141: 158-168, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37742945
16.
Multiparametric Phenotyping of Circulating Tumor Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and DNA Repair Markers.
Cancers (Basel);
14(11)2022 Jun 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35681790
17.
Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer.
Anticancer Res;
42(4): 1739-1747, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35346992
18.
How VEGF-A and its splice variants affect breast cancer development - clinical implications.
Cell Oncol (Dordr);
45(2): 227-239, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35303290
19.
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling.
J Mol Diagn;
24(12): 1254-1263, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36191839
20.
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.
Cancer Res;
82(7): 1321-1339, 2022 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35078818